Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
11/2010
11/24/2010CN1889922B Use of osteopontin in dental formulations
11/24/2010CN101896457A Histone deacetylase inhibitors
11/23/2010CA2478094C Methods of inducing terminal differentiation
11/17/2010EP1896399B1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/11/2010US20100286279 Methods of Synthesis of Certain Hydroxamic Acid Compounds
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100278896 Solid compositions
10/2010
10/28/2010US20100273847 Desferrioxamine conjugates, derivatives and analogues
10/21/2010WO2010119877A1 Process for production of amidine derivative
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/20/2010EP2240436A1 Novel process for the preparation of vorinostat
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1091938B1 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
10/14/2010WO2010115758A2 Fungicidal compounds
10/13/2010CN1939898B Chiral synthesis of combined protein deacetylated enzyme inhibitor
10/13/2010CN101857554A Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/12/2010US7812054 administering methyl (E,5S,6R)-5,6-dihydroxy-8-[2-[(E,3R)-3-hydroxyoct-1-enyl]phenyl]oct-7-enoate, optionally with a cyclooxygenase inhibitor selected from celecoxib, rofecoxib, and valdecoxib, to humans or animals for the treatment of an oral inflammation
10/12/2010CA2467261C Novel benzophenone derivatives or salts thereof
10/07/2010WO2010065709A3 Hydroxamic acid derivatives, preparation and therapeutic uses thereof
10/07/2010US20100256401 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/06/2010EP2236503A1 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
09/2010
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100247454 Compositions for elastogenesis and connective tissue treatment
09/28/2010US7803800 Histone deacetylases inhibitors
09/23/2010US20100240601 Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients
09/16/2010WO2010043904A3 Process for the preparation of vorinostat
09/10/2010WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents
09/02/2010WO2010097586A1 Enzyme inhibitors
08/2010
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7785549 Recycling system for hydroxylamine formation and oximation
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/19/2010US20100210729 Methods of inducing terminal differentiation
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/17/2010CA2527203C Casr antagonist
08/11/2010EP2215052A1 Desferrioxamine conjugates, derivatives and analogues
08/10/2010US7772285 Benzophenone derivatives or salts thereof
08/05/2010WO2010066909A3 New inhibitors for treating diseases associated with an excess transport of hyaluronan
08/05/2010US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors
08/05/2010CA2751033A1 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
07/2010
07/29/2010US20100190766 Antibacterial agents
07/27/2010US7763236 administering a formulation in the form of a toothpaste, mouthwash, mouth spray or chewing gum, comprising osteopontin effective to inhibit plaque bacterial growth on teeth enamel
07/21/2010EP2208721A1 Histone deacetylase inhibitor, composition and use thereof
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/15/2010US20100179326 Benzamide derivative
07/14/2010EP2205563A2 Novel histone deacetylase inhibitors
07/01/2010WO2010072602A1 Substituted amidine compounds for combating animal pests
07/01/2010WO2009053808A3 Histone deacetylase inhibitors
07/01/2010WO2009047615A3 Novel histone deacetylase inhibitors
07/01/2010US20100168242 Polymorphs of suberoylanilide hydroxamic acid
07/01/2010CA2747986A1 Substituted amidine compounds for combating animal pests
06/2010
06/30/2010EP2200975A1 Dual-acting antihypertensive agents
06/30/2010CN101765585A antibacterial agents
06/30/2010CN101759599A Tetracycline compound with amino isonitroso
06/29/2010US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/17/2010WO2010066909A2 New inhibitors for treating diseases associated with an excess transport of hyaluronan
06/17/2010CA2742920A1 New inhibitors for treating diseases associated with an excess transport of hyaluronan
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2417399C Preparation of fatty hydroxamate
06/10/2010WO2010065709A2 Hydroxamic acid derivatives, preparation and therapeutic uses thereof
06/10/2010US20100145034 Selective placement of carbon nanotubes through functionalization
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/03/2010WO2009067856A8 Histone deacetylase inhibitor, composition and use thereof
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010CN101255124B Cinnamide histone deacetylase inhibitor and preparation method thereof
06/01/2010US7728039 such as E-3-(4'-hydroxy-biphenyl-4-yl)-N-hydroxy-acrylamide, useful for the treatment of drug-resistant tumors
05/2010
05/26/2010EP2189442A1 Process and intermediates for the preparation of aliskiren
05/12/2010CN1602291B Novel bensophenone derivatives or salts thereof
05/05/2010CN1951912B Chiral alicyclic hydrocarbon hydroxamic acid derivative preparation method
04/2010
04/29/2010US20100105921 N-heterocyclic carbene (nhc) catalyzed synthesis of hydroxamic acids
04/27/2010US7705053 Benzamide derivative
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/22/2010WO2010043904A2 Improved process
04/22/2010WO2010011318A3 Activatiqn of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
04/22/2010CA2740559A1 Improved process
04/20/2010US7700650 Lipoxin analogs and method for the treatment of periodontal disease
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/07/2010EP2170814A2 Antibacterial agents
04/06/2010US7691849 Carboxamidine derivatives and their use in the treatment of vascular diseases
03/2010
03/30/2010US7687220 Oxime derivatives and use thereof as latent acids
03/25/2010WO2010031750A1 Organic compounds for applications in bacterial infections treatment
03/25/2010CA2737524A1 Organic compounds for applications in bacterial infections treatment
03/24/2010EP2164826A2 Dendritic photoactive compound comprising oxime ester and method for preparing the same
03/24/2010CN101679220A inhibitors of histone deacetylase
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/17/2010CN100594212C Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
03/09/2010US7674788 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors
02/2010
02/25/2010CA2730478A1 Prodrugs of methyl hydrogen fumarate
02/17/2010EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
02/16/2010US7662840 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
01/2010
01/28/2010WO2010010174A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010CA2730208A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 45